Melanoma and Other Skin Cancers

5 protocols meet the specified criteria.

  • 20324

    ON-TRK: PrOspective Non-Interventional Study in Patients with Locally Advanced or Metastatic TRK Fusion Cancer Treated with Larotrectinib

  • A151804

    Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events

  • EAY191

    Molecular Analysis for Combination Therapy Choice (ComboMATCH)

  • EAY191-A3

    A ComboMATCH Treatment Trial: Palbociclib and Binimetinib in RAS-Mutant Cancer

  • S2013

    Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study